or more than a decade, Johnson & Johnson has been recognized by the independent Access to Medicine Foundation as one of the top three companies working to advance access to medicines and technologies in low- and middle-income countries.
This consistent recognition of our leadership is the result of a longstanding, deliberate and focused strategy aimed at solving some of the most difficult global health challenges and advancing equitable access to care for everyone, everywhere.
Learn more about how we never stop working to ensure good health for the people we serve.
We are committed, more than ever before, to advance a safer, healthier and more equitable world where everyone can thrive.
Our Global Public Health unit works to expand equitable access to our medicines and technologies for the world's most underserved people.
Our research and development pipeline focuses heavily on diseases that primarily impact underserved populations—and we integrate access planning into everything we do.
Our 25 years of experience in addressing global health challenges is informing our response to COVID-19, a global crisis that is laying bare the global inequities in accessing care.
We're committed to expanding equitable access to care in Africa by strengthening health systems, supporting frontline health workers and investing in local partnerships.